New treatment tested for severe asthma and nasal polyps
NCT ID NCT05575037
Summary
This study is testing whether the medication dupilumab can help people with aspirin-exacerbated respiratory disease, a condition that causes severe asthma, nasal polyps, and loss of smell. Seventeen participants will receive four doses of the medication over eight weeks. Researchers will measure changes in nasal polyps, breathing, sense of smell, and quality of life to see if the treatment is effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASAL POLYPS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.